histamine has been researched along with melphalan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Johnston, M; Kahlson, G | 1 |
| Bout, A; de Roos, WK; de Vries, MW; de Wilt, JH; Eggermont, AM; ten Hagen, TL; Valerio, D; van der Kaaden, ME; van Tiel, ST | 1 |
| Brunstein, F; de Bruijn, EA; Eggermont, AM; Guetens, G; Hoving, S; Seynhaeve, AL; ten Hagen, TL; van Tiel, ST | 1 |
| aan de Wiel-Ambagtsheer, G; Brunstein, F; de Bruijn, EA; Eggermont, AM; Guetens, G; Hoving, S; ten Hagen, TL | 1 |
| Brunstein, F; de Wiel-Ambagtsheer, Ga; Eggermont, AM; Rens, J; ten Hagen, TL; van Tiel, ST | 1 |
7 other study(ies) available for histamine and melphalan
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Experiments on the inhibition of histamine formation in the rat.
Topics: Animals; Antimetabolites; Biological Assay; Carbon Isotopes; Chloramphenicol; Cyclophosphamide; Female; Flavonoids; Histamine; Melphalan; Rats | 1967 |
Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats.
Topics: Adenoviridae; Animals; Carrier Proteins; Dose-Response Relationship, Drug; Extremities; Gene Transfer Techniques; Histamine; Leukocytes; Male; Melphalan; Neoplasm Transplantation; Osteosarcoma; Perfusion; Promoter Regions, Genetic; Rats; Receptors, Interleukin-3; Sarcoma; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2001 |
Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capillary Permeability; Chemotherapy, Cancer, Regional Perfusion; Drug Synergism; Endothelial Cells; Hindlimb; Histamine; Humans; Male; Melphalan; Necrosis; Rats; Rats, Inbred BN; Receptors, Histamine H1; Receptors, Histamine H2; Sarcoma, Experimental; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins | 2004 |
Decreased response rates by the combination of histamine and IL-2 in melphalan-based isolated limb perfusion.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Capillary Permeability; Chemotherapy, Cancer, Regional Perfusion; Drug Synergism; Histamine; Histamine Agents; Humans; Immunohistochemistry; Interleukin-2; Macrophages; Male; Melphalan; Rats; Rats, Inbred BN; Recombinant Proteins; Sarcoma, Experimental | 2007 |
Synergistic antitumor effects of histamine plus melphalan in isolated hepatic perfusion for liver metastases.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal; Drug Synergism; Histamine; Liver Neoplasms, Experimental; Male; Melphalan; Neoplasm Transplantation; Rats; Sarcoma | 2007 |